1 dataset found

  1. Regeneron's Q1 Earnings Miss Wall Street Expectations Due to Eylea Sales Dip...

    • indexbox.io
    doc, docx, pdf, xls +1
    Updated Jul 1, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    IndexBox Inc. (2025). Regeneron's Q1 Earnings Miss Wall Street Expectations Due to Eylea Sales Dip - News and Statistics - IndexBox [Dataset]. https://www.indexbox.io/blog/regeneron-pharmaceuticals-faces-earnings-decline-amid-eylea-demand-drop/
    Explore at:
    doc, docx, xlsx, pdf, xlsAvailable download formats
    Dataset updated
    Jul 1, 2025
    Dataset provided by
    IndexBox
    Authors
    IndexBox Inc.
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2012 - Jul 1, 2025
    Area covered
    United States
    Variables measured
    Market Size, Market Share, Tariff Rates, Average Price, Export Volume, Import Volume, Demand Elasticity, Market Growth Rate, Market Segmentation, Volume of Production, and 4 more
    Description

    Regeneron Pharmaceuticals' Q1 earnings fall short of expectations amid declining Eylea sales, facing competition and pricing challenges.

  2. Not seeing a result you expected?
    Learn how you can add new datasets to our index.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
IndexBox Inc. (2025). Regeneron's Q1 Earnings Miss Wall Street Expectations Due to Eylea Sales Dip - News and Statistics - IndexBox [Dataset]. https://www.indexbox.io/blog/regeneron-pharmaceuticals-faces-earnings-decline-amid-eylea-demand-drop/
Organization logo

Regeneron's Q1 Earnings Miss Wall Street Expectations Due to Eylea Sales Dip - News and Statistics - IndexBox

Explore at:
doc, docx, xlsx, pdf, xlsAvailable download formats
Dataset updated
Jul 1, 2025
Dataset provided by
IndexBox
Authors
IndexBox Inc.
License

Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically

Time period covered
Jan 1, 2012 - Jul 1, 2025
Area covered
United States
Variables measured
Market Size, Market Share, Tariff Rates, Average Price, Export Volume, Import Volume, Demand Elasticity, Market Growth Rate, Market Segmentation, Volume of Production, and 4 more
Description

Regeneron Pharmaceuticals' Q1 earnings fall short of expectations amid declining Eylea sales, facing competition and pricing challenges.

Search
Clear search
Close search
Google apps
Main menu